Acutus Medical (NASDAQ:AFIB) is a medical device company based in Carlsbad, California, that specializes in the development of advanced electrophysiology mapping and ablation technologies for the treatment of cardiac arrhythmias. Founded in 2011, the company’s core mission is to improve patient outcomes in the diagnosis and treatment of complex heart rhythm disorders, with an emphasis on atrial fibrillation. By combining proprietary ultrasound imaging with high-resolution electrical mapping, Acutus seeks to offer clinicians a comprehensive view of heart activity that supports more precise interventions.
The company’s flagship offering, the AcQMap Imaging and Mapping System, employs noncontact dipole density mapping to create detailed three-dimensional reconstructions of cardiac anatomy and electrical propagation. This platform is designed to integrate with standard electrophysiology lab hardware, providing electrophysiologists with real-time insights into arrhythmia drivers and substrates. In addition, Acutus Medical has developed accessory tools such as the AcQCross™ Transseptal Access System and AcQGuide™ steerable sheath to streamline procedural workflows and enhance catheter control during ablation therapies.
Acutus Medical’s products have received regulatory clearance in multiple regions, including FDA approval in the United States and CE marking in Europe, and the company maintains a growing presence across North America, Europe, the Middle East, and select markets in Asia and Latin America. The company supports its installed base through clinical education programs, field application training, and a network of regional specialists who collaborate with healthcare providers to optimize procedural efficacy and safety.
Leadership at Acutus Medical includes President and Chief Executive Officer R.V. Devarajan, who brings more than two decades of experience in the medical technology industry, and Chief Scientific Officer Dr. Francis E. Marchlinski, a noted electrophysiologist whose research has shaped modern arrhythmia mapping techniques. Supported by a multidisciplinary team of engineers, clinicians, and regulatory experts, Acutus continues to drive innovation in cardiac rhythm management with a focus on expanding access to best-in-class diagnostic and therapeutic solutions.
